2025-03-01
2024-05-19
| Summary | |
|---|---|
| Cancer Type | Gastric Cancer |
| Grade | IIIC |
| Stage | T4N2M0,IIIb |
| Ethnicity | Asian |
| Gender | M |
| Age | 49 |
| Pathology Diagnosis | Moderately-poorly differentiated adenocarcinoma of gastric antrum, with part of signet ring cell carcinoma, ulcerative type, tumor mass: 5.0 x 5.0cm. The tumor invade through gastric wall to serosa of pancreas and gallbladder. Regional LN: NO.1 LN (6/8), NO.3 LN (14/17), NO.5 LN (2/2), NO.6 LN (2/2), NO.7 LN (4/6), NO.4D LN (10/11), NO.8 LN (1/2). IHC results: CD44(+), cMet(weak +), EGFR(+), HER2(3+), Ki-67(+50-75%), MMP7(-), P170(-), P27(+50-75%), P53(+>75%), TOPOII(-). |
| Biopsy Site | primary |
| Treatment History | SOX 2 cycles. Pathology QC: Pa-Mucinous adenocarcinoma; P2-Poorly differentiated adenocarcinoma. |
| Pathology QC | Mucinous adenocarcinoma (Pa), poorly differentiated adenocarcinoma (P2) |
| Special Features | Orthotopic ; ERBB2 amplified |
| Mouse Strain | Balb/c nu |
| TMA | TMA-HP-GA-021 |
| Viral Status in PDX | NA |
| Available In | CB_CN |
| RNA Seq | P2 |
| Exome Seq | P3 |
Already Registered? Login
To view this data, close this window and Log In or Register for Access.
© 2025 Crown Bioscience. All Rights Reserved.
Privacy Policy | Imprint | Terms of Service | Privacy Preferences


© 2025 Crown Bioscience. All Rights Reserved. Privacy Policy